Informations sur le produit
Nom :
Epertinib
Description :
Epertinib is a tyrosine kinase inhibitor that targets epidermal growth factor receptor (EGFR) and HER2. It is used to treat patients with cancer who have specific mutations in the EGFR or HER2 genes. These mutations are found in about 20% of all breast cancers, and may be associated with worse prognosis. Epertinib is active against EGFR-mutated colorectal cancer, lung adenocarcinoma, and some types of brain cancer. It has also been shown to inhibit the growth of solid tumours in mice. In addition, epertinib may be useful for treating metastatic her2-positive breast cancer, as it blocks the growth factor receptor downstream of HER2 signalling (EGFR).
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
560.02 g/mol
Formule :
C30H27ClFN5O3
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
